NKE insider files Form 144 to sell 1,019 Class B shares on NYSE

Rhea-AI Filing Summary

Nike, Inc. (NKE) Form 144: The filing notifies a proposed sale of 1,019 Class B shares with an aggregate market value of $76,058.16 based on an outstanding share count of 1,188,015,740. The planned sale date is 09/05/2025 on the NYSE. The shares were acquired on 09/01/2025 through restricted stock vesting from the issuer, with payment characterized as compensation. The filer also reported a sale during the past three months by Robert Leinwand of 1,644 Class B shares on 08/05/2025 for $123,152.04. The form includes the standard representation that the selling person is not aware of undisclosed material adverse information and a signature/attestation requirement. Certain filer identification fields appear blank in the provided text.

Positive

• Transaction transparency: Filing discloses acquisition date, nature (restricted stock vesting), number of shares, planned sale date, and aggregate market value.
• Compliance language: Attestation that the seller is not aware of undisclosed material adverse information and signature requirement are included.

Negative

• Missing identifier fields: Filer CIK/CCC and certain issuer contact fields are blank in the provided text, limiting traceability.
• Concentration context absent: The filing does not state whether the seller is an officer/director or the relationship beyond the generic section, reducing context for investors.

Insights

Securities Analyst

TL;DR: A company insider plans to sell a modest block of vested Class B shares shortly after vesting; past recent sale by an insider is disclosed.

The notice documents a routine Rule 144 sale following restricted stock vesting. The block to be sold is small relative to the issuer's outstanding shares (1,019 vs 1,188,015,740), and the filing ties the acquisition to compensation with an immediate planned sale date. The prior sale by Robert Leinwand of 1,644 shares three weeks earlier is disclosed with gross proceeds of $123,152.04. These are standard insider liquidity transactions and, based on the information provided, do not indicate material corporate developments. The form lacks explicit filer CIK/issuer address details in the provided text, which limits completeness for compliance tracing.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 mechanics; signatures and attestations are present but some identifying fields are omitted in the excerpt.

The filing shows compliance with Rule 144 by documenting acquisition date, nature (restricted stock vesting), sale amount, and planned sale date on the NYSE. The required attestation about absence of undisclosed material adverse information is included. However, several filer/issuer identification fields in the supplied content are empty, which is notable from a governance and disclosure-completeness standpoint; the filing text as provided does not supply full contact/CIK data. Based solely on the submission content, this appears to be a routine insider sale rather than a governance concern.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class B	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1019	76058.16	1188015740	09/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class B	09/01/2025	Restricted Stock Vesting	Issuer			1019	09/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROBERT LEINWAND One Bowerman Drive Beaverton OR 97005-645	Class B	08/05/2025	1644	123152.04

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the NKE Form 144 propose to sell?

The notice proposes sale of 1,019 Class B shares on the NYSE with an aggregate market value of $76,058.16.

When were the shares acquired and how?

The shares were acquired on 09/01/2025 by restricted stock vesting from the issuer and payment is listed as compensation.

What is the planned sale date for the proposed transaction?

The approximate date of sale is listed as 09/05/2025 on the NYSE.

Were there any insider sales in the past three months disclosed?

Yes. Robert Leinwand sold 1,644 Class B shares on 08/05/2025 for gross proceeds of $123,152.04.

Does the filing include the required attestation about material information?

Yes. The filing includes the representation that the seller does not know of any material adverse information not publicly disclosed and requires a signature.